微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.89% | -48.26% | -77.92% | 74/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 4.03% | 61.85% | -4.73% | 68/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.23% | 41.95% | 27.79% | 65/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.31% | 77.01% | 92.44% | 58/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.72% | 57.8% | -30.92% | 57/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.49% | -49.29% | -16.44% | 90/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 2.98% | -17.91% | 59.36% | 86/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.87% | -39.09% | 71.56% | 85/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.09% | -50.45% | -77.8% | 81/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 4.91% | -41.41% | 35.26% | 92/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 3.63% | -42.83% | 18.24% | 93/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 3.07% | -0.65% | 39.55% | 85/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.2% | 16.4% | -73.75% | 66/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 8.38% | 83.77% | 31.97% | 90/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 6.35% | 59.15% | 105.5% | 85/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.09% | 5.82% | 63.49% | 100/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.89% | 3.85% | -58.55% | 77/131 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 4.56% | -20.83% | 14.29% | 111/131 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 3.99% | -13.82% | 36.64% | 72/131 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 2.92% | -7.01% | 60.44% | 87/131 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.82% | -22.22% | -68.4% | 44/131 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 5.76% | -32% | 24.41% | 93/131 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.63% | -32.8% | 47.45% | 52/131 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 3.14% | -34.85% | 34.19% | 53/131 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.34% | 8.84% | -72.37% | 27/131 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 8.47% | -24.58% | 22.93% | 74/131 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 6.89% | -37.25% | 42.95% | 35/131 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.82% | -37.56% | 124.19% | 28/131 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 2.15% | 2% | -80.85% | 28/131 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 11.23% | -19.21% | 2.28% | 60/131 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 10.98% | 2% | 42.23% | 20/131 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 7.72% | 2% | -44.46% | 22/131 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2016-12-31 | 13.9% | 5.22% | 5.22% | 39/131 | 16.21% | 基蛋生物 | 11.34% | 行业排名> |
| 2015-12-31 | 13.21% | -16.97% | -16.97% | 31/131 | 15.95% | 奥泰生物 | 76.87% | 行业排名> |